Scientific publications continue to arrive at the same painful conclusion: Depression is a major problem across the world, and it’s not going away anytime soon. But though we’re still struggling to ...

Researchers led by Prof. Alessandro Serretti at Kore University of Enna have identified a genetic inflammatory signature that defines specific depression subtypes and influences how patients respond ...

A groundbreaking Genomic Press interview explores Dr. Najaf Amin's innovative approach to depression genetics at Oxford ...

It stands for Psychiatric Renewal Through Innovative Solutions and Methods. There are a couple of high profile treatments, ...

The connection between what we eat and how we feel extends far beyond physical energy levels. Our growing understanding of the gut-brain axis reveals how dietary choices directly influence ...

For decades, psychiatric treatment has focused predominantly on pharmaceutical interventions and psychotherapy while largely overlooking a fundamental factor in brain function: nutrition. This ...

Chronic stress disrupts O-glycans in the mouse prefrontal cortex. The findings open new possibilities for depression treatment.

Esketamine is the first monotherapy for MDD with inadequate response to two oral antidepressants, approved after a priority FDA review. Clinical trials showed esketamine's rapid efficacy, with 22.5% ...

Post-partum depression (PPD) develops after childbirth and affects both the mother's and the infant's health by preventing healthy bonding. Women with PPD experience intense anxiety, feelings of ...

It would not be the first psychiatric drug to run aground in a large study after sailing through early trials. But even though TC-5214 has failed to significantly relieve major depression in a phase ...